Table 1.

Clinical description of the study cohort (n = 27)

Movement Disorder	Number of patients	Age	Sex (M/F)	Days of Hospital Stay	Days Between COVID and movement disorder	Follow Up# [weeks]
Myoclonus	7	58.7 ± 13.1	3/4	20.4 ± 12.1	0,2,4,7,9,25,35	56.7 ± 32.3
Myoclonus-Ataxia	5	57.2 ± 12.4	4/1	12.2 ± 8.1	10,12,14,17; unknown in one case	52.4 ± 31.2
Ataxia	5	53.2 ± 11.4	3/2	16.2 ± 10.2	0, 3, 12, 21; unknown in one case	67.6 ± 20.1
Opsoclonus-Myoclonus-Ataxia	3	46.3 ± 13.0	3/0	5.3 ± 0.5	8, 10, 21	54.7 ± 3,8
Hypokinetic rigid syndrome	3	56 ± 7.5	2/1	48.3 ± 40.0	5, 33; ?44*	67.0 ± 21.2
Tremor	1	62	1/0	37	10	8
Serotonin Syndrome	1	66	1/0	33	3	54
Limb tremor and gait ataxia	1	78	1/0	90	10	81
Chorea	1	58	1/0	13	2	3

^*Onset not clear as the patient was intubated; movement disorder was first observed when the patient was extubated on day 44; # standardised from the outset